Clinical Trial Update: Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates cytotoxicity, leaching, and structural conformation of clear aligner materials used to treat malocclusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malocclusion

Snippet

Sponsor: Riyadh Elm University | Conditions: Malocclusion, Cytotoxicity | Phase 4 | Status: NOT_YET_RECRUITING